UNITED CAPITAL FINANCIAL ADVISORS, LLC - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 167 filers reported holding HALOZYME THERAPEUTICS INC in Q1 2016. The put-call ratio across all filers is 0.15 and the average weighting 0.1%.

Quarter-by-quarter ownership
UNITED CAPITAL FINANCIAL ADVISORS, LLC ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$287,111
+4.2%
7,516
-1.6%
0.00%0.0%
Q2 2023$275,539
-7.8%
7,639
-2.4%
0.00%0.0%
Q1 2023$298,875
-42.0%
7,826
-13.6%
0.00%
-33.3%
Q4 2022$515,514
+44.8%
9,060
+0.7%
0.00%
+50.0%
Q3 2022$356,000
-53.7%
8,995
-48.5%
0.00%
-50.0%
Q2 2022$769,000
+113.6%
17,468
+93.8%
0.00%
+100.0%
Q1 2022$360,0000.0%9,015
+0.6%
0.00%0.0%
Q4 2021$360,000
-1.1%
8,965
+0.1%
0.00%0.0%
Q3 2021$364,000
-10.6%
8,960
-0.1%
0.00%0.0%
Q2 2021$407,000
+8.8%
8,9650.0%0.00%0.0%
Q1 2021$374,000
-2.3%
8,9650.0%0.00%0.0%
Q4 2020$383,000
+63.0%
8,965
+0.1%
0.00%0.0%
Q3 2020$235,000
-2.1%
8,9600.0%0.00%0.0%
Q2 2020$240,000
+96.7%
8,960
-30.2%
0.00%
+100.0%
Q1 2016$122,000
-45.3%
12,8430.0%0.00%
-66.7%
Q4 2015$223,000
+29.7%
12,8430.0%0.00%
+50.0%
Q3 2015$172,000
-40.7%
12,8430.0%0.00%
-33.3%
Q2 2015$290,000
+50.3%
12,843
-1.1%
0.00%
+50.0%
Q1 2015$193,000
-8.1%
12,985
-40.1%
0.00%0.0%
Q4 2014$210,000
+130.8%
21,674
+116.7%
0.00%0.0%
Q3 2014$91,000
-31.6%
10,000
-4.8%
0.00%
-33.3%
Q1 2014$133,000
-36.7%
10,500
-25.0%
0.00%
-57.1%
Q4 2013$210,000
+35.5%
14,0020.0%0.01%
+40.0%
Q3 2013$155,00014,0020.01%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q1 2016
NameSharesValueWeighting ↓
SNYDER CAPITAL MANAGEMENT L P 4,324,232$165,185,6623.73%
Steamboat Capital Partners, LLC 196,898$7,521,5042.79%
2Xideas AG 600,799$22,950,5222.54%
BERNZOTT CAPITAL ADVISORS 171,808$6,563,0662.26%
Redwood Investments, LLC 328,459$12,547,1341.70%
Mesirow Institutional Investment Management, Inc. 380,415$14,531,8531.47%
Granite Investment Partners, LLC 856,253$32,708,8651.37%
Penn Capital Management Company, LLC 324,707$12,453,2111.28%
EFG Asset Management (North America) Corp. 137,739$5,262,3191.25%
First Light Asset Management, LLC 313,536$11,977,0751.14%
View complete list of HALOZYME THERAPEUTICS INC shareholders